Copyright and license agreement
During submission, you will need to accept and confirm the following conditions:
- All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria
- That the article is original, has not already been published in a journal, and is not currently under consideration by another journal
- That you agree to the terms of the BioMed Central Copyright and License Agreement, which we strongly recommend you read and, where applicable, Open Data policy. For authors who are prevented from being the copyright holder (for instance where Crown Copyright applies or researchers are US government employees), BioMed Central can accommodate non-standard copyright lines. If this applies to you, please contact us and provide details of your situation.
For more information see our Copyright and license policy.
An article-processing charge (APC) applies for each article accepted for publication in Cancer Nanotechnology . For further details please see our article-processing-charge page.